Grik1 Antibody
| Code | Size | Price |
|---|
| PSI-4381-0.02mg | 0.02mg | £150.00 |
Quantity:
| PSI-4381-0.1mg | 0.1mg | £449.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Rabbit
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Immunofluorescence (IF)
- Immunohistochemistry (IHC)
- Western Blot (WB)
Documents
Further Information
Additional Names:
Grik1 Antibody: EAA3, EEA3, GLR5, GLUR5, GluK1, Glutamate receptor ionotropic, kainate 1, Excitatory amino acid receptor 3
Application Note:
Grik1 antibody can be used for detection of Grik1 by Western blot at 0.5 - 2 μg/mL. Antibody can also be used for immunohistochemistry starting at 2.5 μg/mL. For immunofluorescence start at 20 μg/mL.
Antibody validated: Western Blot in mouse samples; Immunohistochemistry in human and mouse samples and Immunofluorescence in human and mouse samples. All other applications and species not yet tested.
Antibody validated: Western Blot in mouse samples; Immunohistochemistry in human and mouse samples and Immunofluorescence in human and mouse samples. All other applications and species not yet tested.
Background:
Grik1 Antibody: Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. Grik1, also known as glutamate receptor 5, belongs to the kainate family of glutamate receptors, which are composed of four subunits and function as ligand-activated ion channels. Grik1 is expressed in GABAergic interneurons of the hippocampus and are thought to participate in the formation of various subtypes of kainate receptors with Grik2 and KA2. Stimulation of Grik1 leads to intracellular calcium release and activation of protein kinase C. Excessive activation has been associated with psychiatric, neurological and neurodegenerative diseases. Numerous isoforms of Grik1 are known to exist and may be subject to RNA editing within the second transmembrane domain, which is thought to alter the properties of ion flow.
Background References:
- Tanaka K. Functions of glutamate transports in the brain. Neurosci. Res.2000; 37:15-9.
- Pinheiro P and Mulle C. Kainate receptors. Cell Tissue Res.2006; 326:457-82.
- Bureau I, Dieudonne S, Coussen F, et al. Kainate receptor-mediated responses in the CA1 field of wild-type and GluR6-deficient mice. J. Neurosci.1999; 19:653-63.
- Christensen JK, Paternain AV, Selak S, et al. A mosaic of functional kainate receptors in hippocampal interneurons. J. Neurosci.2004; 24:8986-93.
Buffer:
Grik1 Antibody is supplied in PBS containing 0.02% sodium azide.
Concentration:
1 mg/mL
Conjugate:
Unconjugated
DISCLAIMER:
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Immunogen:
Grik1 antibody was raised against a 15 amino acid synthetic peptide near the carboxy terminus of the human Grik1.
The immunogen is located within the last 50 amino acids of Grik1.
The immunogen is located within the last 50 amino acids of Grik1.
NCBI Gene ID #:
2897
NCBI Official Name:
glutamate receptor, ionotropic, kainate 1
NCBI Official Symbol:
GRIK1
NCBI Organism:
Homo sapiens
Physical State:
Liquid
Protein Accession #:
P39086
Protein GI Number:
729597
Purification:
Grik1 Antibody is affinity chromatography purified via peptide column.
Research Area:
Neuroscience
Swissprot #:
P39086
User NOte:
Optimal dilutions for each application to be determined by the researcher.
Related Products
| Product Name | Product Code | Supplier | Grik1 Peptide | PSI-4381P | ProSci | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|